Frontal Lobe Development in Fetuses With Congenital Heart Disease and Its Relation to Expected Brain Arterial Oxygen

Xiaowei Xiong1,2, Chenxiao Hou3, Jingjing Wang1,2

  • 1Department of Ultrasound, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.

Insights

Congenital heart disease (CHD) in fetuses is linked to impaired frontal lobe growth, potentially due to hypoxia. The frontal lobe anteroposterior to occipitofrontal diameter ratio may help assess fetal brain development in CHD cases.

Area of Science:

  • Fetal Medicine
  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics

Background:

  • Congenital heart disease (CHD) affects fetal development.
  • Understanding neurodevelopmental impacts of CHD is crucial.
  • Fetal frontal lobe development requires further investigation in CHD.

Purpose of the Study:

  • Compare fetal head growth and frontal lobe development in fetuses with and without CHD.
  • Investigate the link between in utero frontal lobe growth and cerebral oxygen saturation (SaO2).

Main Methods:

  • Retrospective study of 634 fetuses with CHD and 677 controls.
  • Fetal ultrasound measurements included biparietal diameter (BPD), head circumference (HC), and frontal lobe anteroposterior diameter (FAPD).
  • Calculated FAPD/occipitofrontal diameter (OFD) ratio to assess frontal lobe growth.

Main Results:

  • Fetuses with CHD showed smaller BPD, HC, and FAPD compared to controls, with reductions decreasing with gestational age.
  • The FAPD/OFD ratio was consistently lower in the CHD group, decreasing with reduced cerebral arterial SaO2.
  • No significant difference in FAPD/OFD ratio was observed between isolated and non-isolated CHD subgroups.

Conclusions:

  • Fetuses with CHD exhibit impaired frontal lobe growth, potentially linked to hypoxia and altered hemodynamics.
  • The FAPD/OFD ratio shows promise as a tool for evaluating fetal frontal lobe development.
  • Cardiac-induced hemodynamic changes may significantly influence neurodevelopment in fetuses with CHD.
Abstract